Skip to content
10-Q

Quarterly Report

PRECIGEN, INC. PGEN

0001356090-25-000019

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 295.18M sh
Short Term Investments Q1 2025 · Mar 31, 2025 $74.18M
Short Term Investments Q1 2025 · Dec 31, 2024 $68.39M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $6.06M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $29.52M
Current Liabilities Q1 2025 · Mar 31, 2025 $23.99M
Current Liabilities Q1 2025 · Dec 31, 2024 $21.52M
Total Liabilities Q1 2025 · Mar 31, 2025 $113.33M
Total Liabilities Q1 2025 · Dec 31, 2024 $78.54M
Current Assets Q1 2025 · Mar 31, 2025 $84.6M
Current Assets Q1 2025 · Dec 31, 2024 $102.41M
Total Assets Q1 2025 · Mar 31, 2025 $128.79M
Total Assets Q1 2025 · Dec 31, 2024 $145.27M
Shares Diluted Q1 2025 · Mar 31, 2024 249.22M sh
Capex Q1 2025 · Mar 31, 2024 $4.35M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$14.09M
Stockholders Equity Q1 2025 · Mar 31, 2024 $97.02M
Stockholders Equity Q1 2025 · Dec 31, 2023 $118.5M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.10
Eps Basic Q1 2025 · Mar 31, 2024 −$0.10
Net Income Q1 2025 · Mar 31, 2024 −$23.74M